nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Acute disseminated encephalomyelitis associated with positive voltage gated potassium channel complex antibody
|
Kaliakatsos, Marios |
|
2013 |
|
2 |
p. 147-150 4 p. |
artikel |
2 |
A pilot MRI study of white and grey matter involvement by multiple sclerosis spinal cord lesions
|
Kearney, H. |
|
2013 |
|
2 |
p. 103-108 6 p. |
artikel |
3 |
Bifactor structure of clinical disability in relapsing multiple sclerosis
|
Chamot, Eric |
|
2014 |
|
2 |
p. 176-185 10 p. |
artikel |
4 |
Bilateral trochlear nerve palsy in a patient with neuromyelitis optica
|
Rizek, Philippe |
|
2014 |
|
2 |
p. 273-275 3 p. |
artikel |
5 |
Burden of multiple sclerosis on direct, indirect costs and quality of life: National US estimates
|
Campbell, Jonathan D. |
|
2014 |
|
2 |
p. 227-236 10 p. |
artikel |
6 |
Cardiovascular autonomic dysfunction in multiple sclerosis: A meta-analysis
|
Racosta, Juan Manuel |
|
2015 |
|
2 |
p. 104-111 8 p. |
artikel |
7 |
CCSVI-A. A call to clinicans and scientists to vocalise in an Internet age
|
Gafson, Arie R. |
|
2014 |
|
2 |
p. 143-146 4 p. |
artikel |
8 |
Chloride channel loss of function linked with white matter disease
|
Dale, Russell C. |
|
2014 |
|
2 |
p. 141-142 2 p. |
artikel |
9 |
Comment on “Hierarchical genetic organization of human cortical surface area” by Chen et al. [Science 335 (2012) 1634–1636 (supporting information)]
|
Ciccarelli, Olga |
|
2013 |
|
2 |
p. 90-91 2 p. |
artikel |
10 |
Corrigendum to “Inflammatory cytokines in relapsing-remitting multiple sclerosis (RRMS) patients” [Mult. Scler. Relat. Disord. 3 (2014) 741]
|
Shajarian, M. |
|
2015 |
|
2 |
p. 180- 1 p. |
artikel |
11 |
Crystal-storing histiocytosis: An unusual relapsing inflammatory CNS disorder
|
Costanzi, Chiara |
|
2012 |
|
2 |
p. 95-99 5 p. |
artikel |
12 |
Does glatiramer acetate provoke hepatitis in multiple sclerosis?
|
Sinagra, Emanuele |
|
2014 |
|
2 |
p. 266-268 3 p. |
artikel |
13 |
ECTRIMS 2012: Treatment highlights
|
Giovannoni, Gavin |
|
2013 |
|
2 |
p. 68-72 5 p. |
artikel |
14 |
Editors’ welcome
|
Banwell, Brenda |
|
2015 |
|
2 |
p. 93-94 2 p. |
artikel |
15 |
Editors’ Welcome
|
Banwell, Brenda |
|
2014 |
|
2 |
p. 139-140 2 p. |
artikel |
16 |
Editors' welcome
|
Banwell, Brenda |
|
2012 |
|
2 |
p. 55- 1 p. |
artikel |
17 |
Editors' welcome and a working definition for a multiple sclerosis cure
|
Banwell, Brenda |
|
2013 |
|
2 |
p. 65-67 3 p. |
artikel |
18 |
Effects of rituximab on lymphocytes in multiple sclerosis and neuromyelitis optica
|
Graves, Jennifer |
|
2014 |
|
2 |
p. 244-252 9 p. |
artikel |
19 |
Elevated relapse rates in pediatric compared to adult MS persist for at least 6 years
|
Benson, L.A. |
|
2014 |
|
2 |
p. 186-193 8 p. |
artikel |
20 |
Emerging disease modifying treatments—A therapeutics update from ECTRIMS/ACTRIMS, Amsterdam, 2011
|
Giovannoni, Gavin |
|
2012 |
|
2 |
p. 56-58 3 p. |
artikel |
21 |
Epstein–Barr virus in the multiple sclerosis brain – An evasive culprit
|
Pender, Michael P. |
|
2012 |
|
2 |
p. 61-63 3 p. |
artikel |
22 |
Fabry disease mimicking multiple sclerosis: Lessons from two case reports
|
Shribman, S.E. |
|
2015 |
|
2 |
p. 170-175 6 p. |
artikel |
23 |
Genetic evidence for a pathogenic role for the vitamin D3 metabolizing enzyme CYP24A1 in multiple sclerosis
|
Ramasamy, Adaikalavan |
|
2014 |
|
2 |
p. 211-219 9 p. |
artikel |
24 |
High-dose intravenous interferon-beta in multiple sclerosis patients with high-titer neutralizing antibodies (HINABS II) – A pilot study
|
Hegen, H. |
|
2014 |
|
2 |
p. 220-226 7 p. |
artikel |
25 |
High doses of biotin in chronic progressive multiple sclerosis: A pilot study
|
Sedel, Frédéric |
|
2015 |
|
2 |
p. 159-169 11 p. |
artikel |
26 |
Improved detection of focal cortical lesions using 7T magnetisation transfer imaging in patients with multiple sclerosis
|
Abdel-Fahim, R. |
|
2014 |
|
2 |
p. 258-265 8 p. |
artikel |
27 |
Increased deep gray matter iron is present in clinically isolated syndromes
|
Quinn, Matthew P. |
|
2014 |
|
2 |
p. 194-202 9 p. |
artikel |
28 |
Is 3D MPRAGE better than the combination DIR/PSIR for cortical lesion detection at 3T MRI?
|
Nelson, Flavia |
|
2014 |
|
2 |
p. 253-257 5 p. |
artikel |
29 |
Late-onset neutropenia during long-term rituximab therapy in neuromyelitis optica
|
Plate, Annika |
|
2014 |
|
2 |
p. 269-272 4 p. |
artikel |
30 |
Lessons from clinical trials of alemtuzumab in multiple sclerosis
|
Chaudhuri, Abhijit |
|
2013 |
|
2 |
p. 92-95 4 p. |
artikel |
31 |
Migraine and multiple sclerosis: Epidemiology and approach to treatment
|
Gelfand, Amy A. |
|
2013 |
|
2 |
p. 73-79 7 p. |
artikel |
32 |
Moving toward earlier treatment of multiple sclerosis: Findings from a decade of clinical trials and implications for clinical practice
|
Freedman, Mark S. |
|
2014 |
|
2 |
p. 147-155 9 p. |
artikel |
33 |
Moyamoya: Another multiple sclerosis mimic
|
Zaheer, Fariha |
|
2012 |
|
2 |
p. 100-103 4 p. |
artikel |
34 |
Multiple sclerosis and risk behavior
|
Hawkes, Christopher H. |
|
2012 |
|
2 |
p. 59-60 2 p. |
artikel |
35 |
Multiple sclerosis in Colombia and other Latin American Countries
|
Toro, Jaime |
|
2013 |
|
2 |
p. 80-89 10 p. |
artikel |
36 |
Multiple sclerosis: The role of melatonin and N-acetylserotonin
|
Anderson, George |
|
2015 |
|
2 |
p. 112-123 12 p. |
artikel |
37 |
Natalizumab-related progressive multifocal leukoencephalopathy in Greece
|
Mitsikostas, Dimos D. |
|
2014 |
|
2 |
p. 203-210 8 p. |
artikel |
38 |
[No title]
|
Murray, Jock |
|
2013 |
|
2 |
p. 151- 1 p. |
artikel |
39 |
Observations on the brain vasculature in multiple sclerosis: A historical perspective
|
Rae-Grant, Alex D. |
|
2014 |
|
2 |
p. 156-162 7 p. |
artikel |
40 |
On the origin of EDSS
|
Kurtzke, John F. |
|
2015 |
|
2 |
p. 95-103 9 p. |
artikel |
41 |
Patient-rated ease of use and functional reliability of an electronic autoinjector for self-injection of subcutaneous interferon beta-1a for relapsing multiple sclerosis
|
Singer, B. |
|
2012 |
|
2 |
p. 87-94 8 p. |
artikel |
42 |
Preserved in vivo response to interferon-alpha in multiple sclerosis patients with neutralising antibodies against interferon-beta (REPAIR study)
|
Magyari, Melinda |
|
2013 |
|
2 |
p. 141-146 6 p. |
artikel |
43 |
Progression of disability in multiple sclerosis: A study of factors influencing median time to reach an EDSS value
|
Ramachandran, Sudarshan |
|
2013 |
|
2 |
p. 109-116 8 p. |
artikel |
44 |
Pseudotumoral rebound of multiple sclerosis in a pregnant patient after stopping natalizumab
|
Verhaeghe, Alexander |
|
2014 |
|
2 |
p. 279-281 3 p. |
artikel |
45 |
Quantification of blood-to-brain transfer rate in multiple sclerosis
|
Taheri, Saeid |
|
2013 |
|
2 |
p. 124-132 9 p. |
artikel |
46 |
Recurrent refrains in a patient with multiple sclerosis: Earworms or musical hallucinations?
|
Husain, Farhat |
|
2014 |
|
2 |
p. 276-278 3 p. |
artikel |
47 |
Regional gray matter atrophy in relapsing remitting multiple sclerosis: Baseline analysis of multi-center data
|
Datta, Sushmita |
|
2015 |
|
2 |
p. 124-136 13 p. |
artikel |
48 |
Relationship between muscle strength parameters and functional capacity in persons with mild to moderate degree multiple sclerosis
|
Kjølhede, Tue |
|
2015 |
|
2 |
p. 151-158 8 p. |
artikel |
49 |
Sample sizes for lesion magnetisation transfer ratio outcomes in remyelination trials for multiple sclerosis
|
Altmann, D.R. |
|
2014 |
|
2 |
p. 237-243 7 p. |
artikel |
50 |
Sexual dysfunction in patients with multiple sclerosis
|
Orasanu, Bogdan |
|
2013 |
|
2 |
p. 117-123 7 p. |
artikel |
51 |
Subclinical MRI disease activity influences cognitive performance in MS patients
|
Damasceno, Alfredo |
|
2015 |
|
2 |
p. 137-143 7 p. |
artikel |
52 |
Teaching case: A man with a progressive gait impairment and visual compromise
|
Toro, Jaime |
|
2015 |
|
2 |
p. 176-179 4 p. |
artikel |
53 |
The biology that underpins the therapeutic potential of cannabis-based medicines for the control of spasticity in multiple sclerosis
|
Baker, David |
|
2012 |
|
2 |
p. 64-75 12 p. |
artikel |
54 |
The CombiRx trial of combined therapy with interferon and glatiramer acetate in relapsing remitting MS: Design and baseline characteristics
|
Lindsey, J.W. |
|
2012 |
|
2 |
p. 81-86 6 p. |
artikel |
55 |
The effect of daclizumab on brain atrophy in relapsing-remitting multiple sclerosis
|
Borges, Isabela T. |
|
2013 |
|
2 |
p. 133-140 8 p. |
artikel |
56 |
The epigenetics of multiple sclerosis and other related disorders
|
van den Elsen, Peter J. |
|
2014 |
|
2 |
p. 163-175 13 p. |
artikel |
57 |
Unmet needs of multiple sclerosis patients in the community
|
Lonergan, Roisin |
|
2015 |
|
2 |
p. 144-150 7 p. |
artikel |
58 |
Urine: An under-studied source of biomarkers in multiple sclerosis?
|
Dobson, Ruth |
|
2012 |
|
2 |
p. 76-80 5 p. |
artikel |
59 |
Views on disclosing mistreatment: A focus group study of differences between people with MS and their caregivers
|
Shapiro, Johanna |
|
2013 |
|
2 |
p. 96-102 7 p. |
artikel |